Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced with deep sadness the ...
2don MSN
Trend International Holding disclosed a position in packaging and aerospace firm TriMas. Carlyle Group lowered its stake ...
We recently published a list of 10 Most Promising Small-Cap Stocks According to Hedge Funds. In this article, we are going to ...
Looking at options history for Soleno Therapeutics SLNO we detected 10 trades. If we consider the specifics of each trade, it ...
Soleno Therapeutics (SLNO) shares rose 15% in premarket trade after FDA announced no advisory committee meeting needed for ...
On Tuesday, Soleno Therapeutics Inc (SLNO) stock saw a modest uptick, ending the day at $51.97 which represents a slight increase of $4.34 or 9.11% from the prior close of $47.63. The stock opened at ...
Soleno Therapeutics shows promise with DCCR for reducing hyperphagia in PWS patients. Learn more about why SLNO stock is ...
On Thursday, Soleno Therapeutics Inc (SLNO) stock saw a decline, ending the day at $50.8 which represents a decrease of $-0.28 or -0.55% from the prior close of $51.08. The stock opened at $50.48 and ...
REDWOOD CITY, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 11,478 put options on the company. This is an increase ...
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report) today and set a price target ...
We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback